-
1
-
-
0141741347
-
Parkinson's disease: Mechanisms and models
-
Dauer W, Przedborski S. Parkinson's disease: Mechanisms and models. Neuron. 2003;39:889-909.
-
(2003)
Neuron
, vol.39
, pp. 889-909
-
-
Dauer, W.1
Przedborski, S.2
-
3
-
-
0038632257
-
Clinical characteristics of the alpha- synuclein mutation (G209A)-associated Parkinson's disease in comparison with other forms of familial Parkinson's disease in Greece
-
Papapetropoulos S, Ellul J, Paschalis C, Athanassiadou A, Papadimitriou A, Papapetropoulos T. Clinical characteristics of the alpha- synuclein mutation (G209A)-associated Parkinson's disease in comparison with other forms of familial Parkinson's disease in Greece. Eur J Neurol. 2003;10:281.
-
(2003)
Eur J Neurol
, vol.10
, pp. 281
-
-
Papapetropoulos, S.1
Ellul, J.2
Paschalis, C.3
Athanassiadou, A.4
Papadimitriou, A.5
Papapetropoulos, T.6
-
4
-
-
55949092886
-
Alpha-synuclein misfolding and neurodegenerative diseases
-
Uversky VN. Alpha-synuclein misfolding and neurodegenerative diseases. Curr Protein Pept Sci. 2008;9:507-540.
-
(2008)
Curr Protein Pept Sci
, vol.9
, pp. 507-540
-
-
Uversky, V.N.1
-
5
-
-
33846996820
-
Pesticide exposure and self-reported Parkinson's disease in the agricultural health study
-
Kamel F, Tanner C, Umbach D, et al. Pesticide exposure and self-reported Parkinson's disease in the agricultural health study. Am J Epidemiol. 2007;165:364-374.
-
(2007)
Am J Epidemiol
, vol.165
, pp. 364-374
-
-
Kamel, F.1
Tanner, C.2
Umbach, D.3
-
6
-
-
42449155102
-
Pesticide exposure and risk of Parkinson's disease: A family-based case-control study
-
Hancock DB, Martin ER, Mayhew GM, et al. Pesticide exposure and risk of Parkinson's disease: A family-based case-control study. BMC Neurol. 2008;8:6.
-
(2008)
BMC Neurol
, vol.8
, pp. 6
-
-
Hancock, D.B.1
Martin, E.R.2
Mayhew, G.M.3
-
7
-
-
63649095770
-
Parkinson's disease and residential exposure to maneb and paraquat from agricultural applications in the Central Valley of California
-
Costello S, Cockburn M, Bronstein J, Zhang X, Ritz B. Parkinson's disease and residential exposure to maneb and paraquat from agricultural applications in the Central Valley of California. Am J Epidemiol. 2009;169: 919-926.
-
(2009)
Am J Epidemiol
, vol.169
, pp. 919-926
-
-
Costello, S.1
Cockburn, M.2
Bronstein, J.3
Zhang, X.4
Ritz, B.5
-
8
-
-
21144447013
-
Searching for a relationship between manganese and welding and Parkinson's disease
-
Jankovic J. Searching for a relationship between manganese and welding and Parkinson's disease. Neurology. 2005;12: 2021-2028.
-
(2005)
Neurology
, vol.12
, pp. 2021-2028
-
-
Jankovic, J.1
-
9
-
-
57749178575
-
Dietary iron intake and risk of Parkinson's disease
-
Logroscino G, Gao X, Chen H, Wing A, Ascherio A. Dietary iron intake and risk of Parkinson's disease. Am J Epidemiol. 2008; 12:1381-1388.
-
(2008)
Am J Epidemiol
, vol.12
, pp. 1381-1388
-
-
Logroscino, G.1
Gao, X.2
Chen, H.3
Wing, A.4
Ascherio, A.5
-
10
-
-
71049137290
-
Identification of L-ferritin in neuromelanin granules of the human substantia nigra: A targeted proteomics approach
-
Tribl F, Asan E, Arzberger T, et al. Identification of L-ferritin in neuromelanin granules of the human substantia nigra: A targeted proteomics approach. Mol Cell Proteomics. 2009; 8: 1832.
-
(2009)
Mol Cell Proteomics
, vol.8
, pp. 1832
-
-
Tribl, F.1
Asan, E.2
Arzberger, T.3
-
11
-
-
24944450803
-
Subcellular proteomics of neuromelanin granules isolated from the human brain
-
Tribil F, Gerlach M, Marcus K, et al. Subcellular proteomics of neu- romelanin granules isolated from the human brain. Mol Cell Proteomics. 2005; 4: 945-957.
-
(2005)
Mol Cell Proteomics
, vol.4
, pp. 945-957
-
-
Tribil, F.1
Gerlach, M.2
Marcus, K.3
-
12
-
-
33646948530
-
Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled
-
Keeney PM, Xie J, Capaldi RA, Bennett JP Jr. Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J Neurosci. 2006; 26: 5256-5264.
-
(2006)
J Neurosci
, vol.26
, pp. 5256-5264
-
-
Keeney, P.M.1
Xie, J.2
Capaldi, R.A.3
Bennett Jr., J.P.4
-
13
-
-
45449100897
-
Mitochondrial function in Parkinson's disease cybrids containing an nt2 neuron-like nuclear background
-
Esteves AR, Domingues AF, Ferreira IL, et al. Mitochondrial function in Parkinson's disease cybrids containing an nt2 neuron-like nuclear background. Mitochondrion. 2008; 8: 219-228.
-
(2008)
Mitochondrion
, vol.8
, pp. 219-228
-
-
Esteves, A.R.1
Domingues, A.F.2
Ferreira, I.L.3
-
14
-
-
57349130113
-
A mitochondrial etiology of neurodegenerative diseases: Evidence from Parkinson's disease
-
Khusnutdinova E, Gilyazova I, Ruiz-Pesini E, et al. A mitochondrial etiology of neurodegenerative diseases: Evidence from Parkinson's disease. Ann N Y Acad Sci. 2008; 1147:1-20.
-
(2008)
Ann N Y Acad Sci
, vol.1147
, pp. 1-20
-
-
Khusnutdinova, E.1
Gilyazova, I.2
Ruiz-Pesini, E.3
-
15
-
-
57649210194
-
Impairing the mitochondrial fission and fusion balance: A new mechanism of neurodegeneration
-
Knott AB, Bossy-Wetzel E. Impairing the mitochondrial fission and fusion balance: A new mechanism of neurodegeneration. Ann N Y Acad Sci. 2008; 1147:283-292.
-
(2008)
Ann N Y Acad Sci
, vol.1147
, pp. 283-292
-
-
Knott, A.B.1
Bossy-Wetzel, E.2
-
16
-
-
78650717751
-
Functional implications
-
Mannella C. Functional implications. Ann N Y Acad Sci. 2008; 1147: 147-179.
-
(2008)
Ann N Y Acad Sci
, vol.1147
, pp. 147-179
-
-
Mannella, C.1
-
17
-
-
57749101148
-
Multinuclear magnetic resonance spectroscopy for in vivo assessment of mitochondrial dysfunction in Parkinson's disease
-
Henchcliffe C, Shungu DC, Mao X, et al. Multinuclear magnetic resonance spectroscopy for in vivo assessment of mitochondrial dysfunction in Parkinson's disease. Ann N Y Acad Sci. 2008; 1147: 206-220.
-
(2008)
Ann N Y Acad Sci
, vol.1147
, pp. 206-220
-
-
Henchcliffe, C.1
Shungu, D.C.2
Mao, X.3
-
18
-
-
34247366072
-
Inflammation as a causative factor in the aetiology of Parkinson's disease
-
Whitton PS. Inflammation as a causative factor in the aetiology of Parkinson's disease. Br J Pharm. 2007; 50: 963-976.
-
(2007)
Br J Pharm
, vol.50
, pp. 963-976
-
-
Whitton, P.S.1
-
20
-
-
43549111605
-
Inflammation in Parkinson's disease: An update
-
Smith PF. Inflammation in Parkinson's disease: An update. Curr Opin Invest Drug. 2008;9: 478-484.
-
(2008)
Curr Opin Invest Drug
, vol.9
, pp. 478-484
-
-
Smith, P.F.1
-
21
-
-
44149103168
-
Neuroinflammation and peripheral immune infiltration in Parkinson's disease: An autoimmune hypothesis
-
Monahan AJ, Warren M, Carvey PM. Neuroinflammation and peripheral immune infiltration in Parkinson's disease: An autoimmune hypothesis. Cell Transplant. 2008;4:363-372.
-
(2008)
Cell Transplant
, vol.4
, pp. 363-372
-
-
Monahan, A.J.1
Warren, M.2
Carvey, P.M.3
-
22
-
-
34248400478
-
Therapeutic approaches to inflammation in neurodegenerative disease
-
Klegeris A, McGeer EG, McGeer P. Therapeutic approaches to inflammation in neurodegenerative disease. Curr Opin Neurol. 2007; 20:351-357.
-
(2007)
Curr Opin Neurol
, vol.20
, pp. 351-357
-
-
Klegeris, A.1
McGeer, E.G.2
McGeer, P.3
-
23
-
-
16344386871
-
The role of microglia in paraquat-induced dopaminergic neurotoxicity
-
Wu XF, Block ML, Zhang W, et al. The role of microglia in paraquat-induced dopaminergic neurotoxicity. Antioxid Redox Signal. 2005;7:654-661.
-
(2005)
Antioxid Redox Signal
, vol.7
, pp. 654-661
-
-
Wu, X.F.1
Block, M.L.2
Zhang, W.3
-
24
-
-
33749570292
-
Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease
-
Anderson JP, Walker DE, Goldstein JM, et al. Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J Biol Chem. 2006; 281: 29739-29752.
-
(2006)
J Biol Chem
, vol.281
, pp. 29739-29752
-
-
Anderson, J.P.1
Walker, D.E.2
Goldstein, J.M.3
-
25
-
-
57649233172
-
Mitochondria-targeted anti- oxidants in the treatment of disease
-
Smith RA, Adlam VJ, Blaikie FH, et al. Mitochondria-targeted anti- oxidants in the treatment of disease. Ann N Y Acad Sci. 2008;1147: 105-111.
-
(2008)
Ann N Y Acad Sci
, vol.1147
, pp. 105-111
-
-
Smith, R.A.1
Adlam, V.J.2
Blaikie, F.H.3
-
26
-
-
34248995257
-
The action potential in mammalian central neurons
-
Bean BP. The action potential in mammalian central neurons. Nat Rev Neurosci. 2007; 8: 451-465.
-
(2007)
Nat Rev Neurosci
, vol.8
, pp. 451-465
-
-
Bean, B.P.1
-
27
-
-
34347359673
-
'Rejuvenation' protects neurons in mouse models of Parkinson's disease
-
Chan CS, Guzman JN, Ilijic E, et al. 'Rejuvenation' protects neurons in mouse models of Parkinson's disease. Nature. 2007;447: 1081-1086.
-
(2007)
Nature
, vol.447
, pp. 1081-1086
-
-
Chan, C.S.1
Guzman, J.N.2
Ilijic, E.3
-
28
-
-
61449156563
-
Targeting proteins for destruction by the ubiquitin system: Implications for human pathobiology
-
Schwartz A, Ciechanover A. Targeting proteins for destruction by the ubiquitin system: Implications for human pathobiology. Annu Rev Pharmacol Toxicol. 2009;49:73-96.
-
(2009)
Annu Rev Pharmacol Toxicol
, vol.49
, pp. 73-96
-
-
Schwartz, A.1
Ciechanover, A.2
-
29
-
-
40549090917
-
Ubiquitination of α-synuclein by Siah-1 promotes α-synuclein aggregation and apoptotic cell death
-
Lee JT, Wheeler TC, Li L, Chin LS. Ubiquitination of α-synuclein by Siah-1 promotes α-synuclein aggregation and apoptotic cell death. Hum Mol Genet. 2008;17:906-917.
-
(2008)
Hum Mol Genet
, vol.17
, pp. 906-917
-
-
Lee, J.T.1
Wheeler, T.C.2
Li, L.3
Chin, L.S.4
-
30
-
-
2442645048
-
Proteasome inhibition alters neural mitochondrial homeostasis and mitochondria turnover
-
Sullivan PG, Dragicevic NB, Deng J-H, et al. Proteasome inhibition alters neural mitochondrial homeostasis and mitochondria turnover. J Biol Chem. 2004;279:20699-20707.
-
(2004)
J Biol Chem
, vol.279
, pp. 20699-20707
-
-
Sullivan, P.G.1
Dragicevic, N.B.2
Deng, J.-H.3
-
31
-
-
0021225314
-
Repression of L-arginine: Glycine amidinotransferase synthesis by creatine at a pretranslational level
-
McGuire DM, Gross MD, Van Pilsum JF, Towle HC. Repression of L-arginine: glycine amidinotransferase synthesis by creatine at a pretranslational level. J Biol Chem. 1984;259:12034-12038.
-
(1984)
J Biol Chem
, vol.259
, pp. 12034-12038
-
-
McGuire, D.M.1
Gross, M.D.2
Van Pilsum, J.F.3
Towle, H.C.4
-
32
-
-
60849116967
-
Creatine synthesis: Hepatic metabolism of guanidinoacetate and creatine in the rat in vitro and in vivo
-
Da Silva RP, Nissim I, Brosnan ME, Brosnan JT. Creatine synthesis: Hepatic metabolism of guanidinoacetate and creatine in the rat in vitro and in vivo. Am J Physiol Endocrinol Metab. 2009; 296: E256-E261.
-
(2009)
Am J Physiol Endocrinol Metab
, vol.296
-
-
da Silva, R.P.1
Nissim, I.2
Brosnan, M.E.3
Brosnan, J.T.4
-
33
-
-
67649995770
-
Creatine synthesis is a major metabolic process in neonatal piglets and has important implications for amino acid metabolism and methyl balance
-
Brosnan JT, Wijekoon EP, Warford-Woolgar L, et al. Creatine synthesis is a major metabolic process in neonatal piglets and has important implications for amino acid metabolism and methyl balance. J Nutr. 2009;139:1292-1297.
-
(2009)
J Nutr
, vol.139
, pp. 1292-1297
-
-
Brosnan, J.T.1
Wijekoon, E.P.2
Warford-Woolgar, L.3
-
34
-
-
0346816570
-
Effects of creatine supplementation and resistance training on muscle strength and weightlifting performance
-
Rawson ES, Volek JS. Effects of creatine supplementation and resistance training on muscle strength and weightlifting performance. J Strength Cond Res. 2003;4:822-831.
-
(2003)
J Strength Cond Res
, vol.4
, pp. 822-831
-
-
Rawson, E.S.1
Volek, J.S.2
-
35
-
-
38949116663
-
Effects of resistance exercise with and without creatine supplementation on gene expression and cell signaling in human skeletal muscle
-
Deldicque L, Atherton P, Patel R, et al. Effects of resistance exercise with and without creatine supplementation on gene expression and cell signaling in human skeletal muscle. J Appl Physiol. 2008; 2:371-378.
-
(2008)
J Appl Physiol
, vol.2
, pp. 371-378
-
-
Deldicque, L.1
Atherton, P.2
Patel, R.3
-
36
-
-
67649246832
-
Creatine supplementation enhances muscle force recovery after eccentrically- induced muscle damage in healthy individuals
-
Cooke MB, Rybalka E, Williams AD, Cribb PJ, Hayes AJ. Creatine supplementation enhances muscle force recovery after eccentrically- induced muscle damage in healthy individuals. Int Soc Sports Nutr. 2009; 6:13.
-
(2009)
Int Soc Sports Nutr
, vol.6
, pp. 13
-
-
Cooke, M.B.1
Rybalka, E.2
Williams, A.D.3
Cribb, P.J.4
Hayes, A.J.5
-
37
-
-
0038381490
-
Inhibi- tion of the mitochondrial permeability transition by creatine kinase substrates
-
Requirement for microcompartmentation
-
Dolder M, Walzel B, Speer O, Schlattner U, Wallimann T. Inhibi- tion of the mitochondrial permeability transition by creatine kinase substrates. Requirement for microcompartmentation. J Biol Chem. 2003; 278:17760-17766.
-
(2003)
J Biol Chem
, vol.278
, pp. 17760-17766
-
-
Dolder, M.1
Walzel, B.2
Speer, O.3
Schlattner, U.4
Wallimann, T.5
-
38
-
-
0035002174
-
Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders
-
Tarnopolsky MA, Beal MF. Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders. Ann Neurol. 2001;49:561-574.
-
(2001)
Ann Neurol
, vol.49
, pp. 561-574
-
-
Tarnopolsky, M.A.1
Beal, M.F.2
-
39
-
-
0032854736
-
Molecular characterization of the human CRT-1 creatine transporter expressed in Xenopus oocytes
-
Dai W, Vinnakota S, Qian X, Kunze DL, Sarkar HK. Molecular characterization of the human CRT-1 creatine transporter expressed in Xenopus oocytes. Arch Biochem Biophys. 1999;361:75-84.
-
(1999)
Arch Biochem Biophys
, vol.361
, pp. 75-84
-
-
Dai, W.1
Vinnakota, S.2
Qian, X.3
Kunze, D.L.4
Sarkar, H.K.5
-
40
-
-
0343022262
-
Creatine monohydrate in muscular dystrophies: A double-blind, placebo-controlled clinical study
-
Walter MC, Lochmuller H, Reilich P, et al. Creatine monohydrate in muscular dystrophies: A double-blind, placebo-controlled clinical study. Neurology. 2000;54:1848-1850.
-
(2000)
Neurology
, vol.54
, pp. 1848-1850
-
-
Walter, M.C.1
Lochmuller, H.2
Reilich, P.3
-
41
-
-
0033541016
-
Creatine monohydrate increases strength in patients with neuromuscular disease
-
Tarnopolsky M, Martin J. Creatine monohydrate increases strength in patients with neuromuscular disease. Neurology. 1999;52:854-857.
-
(1999)
Neurology
, vol.52
, pp. 854-857
-
-
Tarnopolsky, M.1
Martin, J.2
-
42
-
-
0031977802
-
The effect of dietary creatine supplementation on skeletal muscle metabolism in congestive heart failure
-
Andrews R, Greenhaff P, Curtis S, Perry A, Cowley AJ. The effect of dietary creatine supplementation on skeletal muscle metabolism in congestive heart failure. Eur Heart J. 1998;19:617-622.
-
(1998)
Eur Heart J
, vol.19
, pp. 617-622
-
-
Andrews, R.1
Greenhaff, P.2
Curtis, S.3
Perry, A.4
Cowley, A.J.5
-
43
-
-
0028597053
-
Nutritional assessment and muscle energy metabolism in severe chronic congestive heart failure - effects of long-term dietary supplementation
-
Broqvist M, Arnqvist H, Dahlstrom U, Larsson J, Nylander E, Permert J. Nutritional assessment and muscle energy metabolism in severe chronic congestive heart failure - effects of long-term dietary supplementation. Eur Heart J. 1994;15:1641-1650.
-
(1994)
Eur Heart J
, vol.15
, pp. 1641-1650
-
-
Broqvist, M.1
Arnqvist, H.2
Dahlstrom, U.3
Larsson, J.4
Nylander, E.5
Permert, J.6
-
44
-
-
0036200845
-
Creatine supplementation improves muscular performance in older men
-
Gotshalk LA, Volek JS, Staron RS, Denegar CR, Hagerman FC, Kraemer WJ. Creatine supplementation improves muscular performance in older men. Med Sci Sports Exerc. 2002;34:537-543.
-
(2002)
Med Sci Sports Exerc
, vol.34
, pp. 537-543
-
-
Gotshalk, L.A.1
Volek, J.S.2
Staron, R.S.3
Denegar, C.R.4
Hagerman, F.C.5
Kraemer, W.J.6
-
45
-
-
3242657936
-
Effect of ceasing creatine supplementation while maintaining resistance training in older men
-
Candow DG, Chilibeck PD, Chad KE, Chrusch MJ, Davison KS, Burke DG. Effect of ceasing creatine supplementation while maintaining resistance training in older men. J Aging Phys Act. 2004; 12:219-231.
-
(2004)
J Aging Phys Act
, vol.12
, pp. 219-231
-
-
Candow, D.G.1
Chilibeck, P.D.2
Chad, K.E.3
Chrusch, M.J.4
Davison, K.S.5
Burke, D.G.6
-
46
-
-
68249158146
-
Effect of creatine supplementation during cast-induced immobilization on the preservation of muscle mass, strength, and endurance
-
Johnston APW, Burke DG, MacNeil LG, Candow DG. Effect of creatine supplementation during cast-induced immobilization on the preservation of muscle mass, strength, and endurance. J Strength Cond Res. 2009;23:116-120.
-
(2009)
J Strength Cond Res
, vol.23
, pp. 116-120
-
-
Johnston, A.P.W.1
Burke, D.G.2
Macneil, L.G.3
Candow, D.G.4
-
47
-
-
12244277899
-
Creatine depletion in a new case with AGAT deficiency: Clinical and genetic study in a large pedigree
-
Battini R, Leuzzi V, Carducci C, et al. Creatine depletion in a new case with AGAT deficiency: Clinical and genetic study in a large pedigree. Molec Genet Metab. 2002;77:326-331.
-
(2002)
Molec Genet Metab
, vol.77
, pp. 326-331
-
-
Battini, R.1
Leuzzi, V.2
Carducci, C.3
-
48
-
-
0037306564
-
Creatine deficiency syndromes
-
Schulze A. Creatine deficiency syndromes. Mol Cell Biochem. 2003;244:143-150.
-
(2003)
Mol Cell Biochem
, vol.244
, pp. 143-150
-
-
Schulze, A.1
-
49
-
-
0142074341
-
Oral creatine mono- hydrate supplementation improves brain performance: A double- blind, placebo-controlled, cross-over trial
-
Rae C, Digney AL, McEwan SR, Bates TC. Oral creatine mono- hydrate supplementation improves brain performance: A double- blind, placebo-controlled, cross-over trial. Proc Biol Sci. 2003;270: 2147-2150.
-
(2003)
Proc Biol Sci
, vol.270
, pp. 2147-2150
-
-
Rae, C.1
Digney, A.L.2
McEwan, S.R.3
Bates, T.C.4
-
50
-
-
33344471016
-
Effect of creatine supplementation and sleep deprivation, with mild exercise, on cognitive and psychomotor performance, mood state, and plasma concentrations of catecholamines and cortisol
-
McMorris T, Harris RC, Swain J, et al. Effect of creatine supplementation and sleep deprivation, with mild exercise, on cognitive and psychomotor performance, mood state, and plasma concentrations of catecholamines and cortisol. Psychopharmacology (Berl). 2006;185:93-103.
-
(2006)
Psychopharmacology (Berl)
, vol.185
, pp. 93-103
-
-
McMorris, T.1
Harris, R.C.2
Swain, J.3
-
51
-
-
34548496865
-
Creatine supple- mentation and cognitive performance in elderly individuals
-
McMorris T, Mielcarz G, Harris RC, Swain JP, Howard A. Creatine supple- mentation and cognitive performance in elderly individuals. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2007;14:517-528.
-
(2007)
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn
, vol.14
, pp. 517-528
-
-
McMorris, T.1
Mielcarz, G.2
Harris, R.C.3
Swain, J.P.4
Howard, A.5
-
52
-
-
0042804970
-
Creatine diet supplement for spinal cord injury: Influences on functional recovery and tissue sparing in rats
-
Rabchevsky AG, Sullivan PG, Fugaccia I, Scheff SW. Creatine diet supplement for spinal cord injury: Influences on functional recovery and tissue sparing in rats. J Neurotrauma. 2003;20:659-669
-
(2003)
J Neurotrauma
, vol.20
, pp. 659-669
-
-
Rabchevsky, A.G.1
Sullivan, P.G.2
Fugaccia, I.3
Scheff, S.W.4
-
53
-
-
0036711579
-
Protective effects of oral creatine supplementation on spinal cord injury in rats
-
Hausmann ON, Fouad K, Wallimann T, Schwab ME. Protective effects of oral creatine supplementation on spinal cord injury in rats. Spinal Cord. 2002;40:449-456.
-
(2002)
Spinal Cord
, vol.40
, pp. 449-456
-
-
Hausmann, O.N.1
Fouad, K.2
Wallimann, T.3
Schwab, M.E.4
-
55
-
-
0036949481
-
Neuroprotection of creatine supplementation in neonatal rats with transient cerebral hypoxia-ischemia
-
Adcock KH, Nedelcu J, Loenneker T, Martin E, Willimann T, Wagner BP. Neuroprotection of creatine supplementation in neonatal rats with transient cerebral hypoxia-ischemia. Dev Neurosci. 2002;24:382-388.
-
(2002)
Dev Neurosci
, vol.24
, pp. 382-388
-
-
Adcock, K.H.1
Nedelcu, J.2
Loenneker, T.3
Martin, E.4
Willimann, T.5
Wagner, B.P.6
-
56
-
-
3042796442
-
Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in mice
-
Zhu S, Li M, Figueroa BE, et al. Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in mice. J Neurosci. 2004;24:5909-5912.
-
(2004)
J Neurosci
, vol.24
, pp. 5909-5912
-
-
Zhu, S.1
Li, M.2
Figueroa, B.E.3
-
57
-
-
33847229764
-
Improved reperfusion and neuroprotection by creatine in a mouse model of stroke
-
Prass K, Royl G, Lindauer U, et al. Improved reperfusion and neuroprotection by creatine in a mouse model of stroke. J Cereb Blood Flow Metab. 2007;27:452-459.
-
(2007)
J Cereb Blood Flow Metab
, vol.27
, pp. 452-459
-
-
Prass, K.1
Royl, G.2
Lindauer, U.3
-
58
-
-
57649171115
-
Mitochondrial approaches for neuroprotection
-
Chaturvedi RK, Beal MF. Mitochondrial approaches for neuroprotection. Ann N Y Acad Sci. 2008;1147:395-412.
-
(2008)
Ann N Y Acad Sci
, vol.1147
, pp. 395-412
-
-
Chaturvedi, R.K.1
Beal, M.F.2
-
59
-
-
0034208612
-
Oral administration of creatine monohydrate retards progression of motor neuron disease in the wobbler mouse
-
Ikeda K, Iwasaki Y, Kinoshita M. Oral administration of creatine monohydrate retards progression of motor neuron disease in the wobbler mouse. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:207-212.
-
(2000)
Amyotroph Lateral Scler Other Motor Neuron Disord
, vol.1
, pp. 207-212
-
-
Ikeda, K.1
Iwasaki, Y.2
Kinoshita, M.3
-
60
-
-
0038115294
-
Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice
-
Dedeoglu A, Kubilus JK, Yang L, et al. Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice. J Neurochem. 2008;85:1359-1367.
-
(2008)
J Neurochem
, vol.85
, pp. 1359-1367
-
-
Dedeoglu, A.1
Kubilus, J.K.2
Yang, L.3
-
62
-
-
33644927838
-
Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 9OH2'dG
-
Hersch SM, Gevorkian S, Marder K, et al. Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 9OH2'dG. Neurology. 2006;66:250-262.
-
(2006)
Neurology
, vol.66
, pp. 250-262
-
-
Hersch, S.M.1
Gevorkian, S.2
Marder, K.3
-
63
-
-
0032914740
-
Creatine and cyclocreatine attenuate MPTP neurotoxicity
-
Matthews RT, Ferrante RJ, Klivenyi P, et al. Creatine and cyclocreatine attenuate MPTP neurotoxicity. Exp Neurol. 1999;157:142-149.
-
(1999)
Exp Neurol
, vol.157
, pp. 142-149
-
-
Matthews, R.T.1
Ferrante, R.J.2
Klivenyi, P.3
-
64
-
-
0036294859
-
Direct antioxidant properties of creatine
-
Lawler JM, Barnes WS, Wu G, Song W, Demaree S. Direct anti- oxidant properties of creatine. Biochem Biophys Res Commun. 2002;290:47-52.
-
(2002)
Biochem Biophys Res Commun
, vol.290
, pp. 47-52
-
-
Lawler, J.M.1
Barnes, W.S.2
Wu, G.3
Song, W.4
Demaree, S.5
-
65
-
-
3142514196
-
Oxidative stress in neurodegeneration: Cause or consequence?
-
Anderson JK. Oxidative stress in neurodegeneration: Cause or consequence? Nat Rev Neurosci. 2004;5:S18-S25.
-
(2004)
Nat Rev Neurosci
, vol.5
-
-
Anderson, J.K.1
-
66
-
-
12844260125
-
Octameric mitochondrial creatine kinase induces and stabilizes contact sites between the inner and outer membrane
-
Speer O, Back N, Buerklen T, et al. Octameric mitochondrial creatine kinase induces and stabilizes contact sites between the inner and outer membrane. Biochem J. 2005;85:445-450.
-
(2005)
Biochem J
, vol.85
, pp. 445-450
-
-
Speer, O.1
Back, N.2
Buerklen, T.3
-
68
-
-
34250308322
-
Apoptosis
-
A review of programmed cell death
-
Elmore S. Apoptosis. A review of programmed cell death. Toxicol Pathol. 2007;35:495-516.
-
(2007)
Toxicol Pathol
, vol.35
, pp. 495-516
-
-
Elmore, S.1
-
69
-
-
68149131973
-
Several nuclear events during apoptosis depend on caspase-3 activation but do not constitute a common pathway
-
Trisciuoglio L, Emilio Bianchi ME. Several nuclear events during apoptosis depend on caspase-3 activation but do not constitute a common pathway. PLoS ONE. 2009;4:e6234.
-
(2009)
PLoS ONE
, vol.4
-
-
Trisciuoglio, L.1
Emilio, B.M.E.2
-
70
-
-
0027300802
-
Functional coupling between sarcoplasmic reticulum-bound creatine kinase and Ca(2+)-ATPase
-
Korge P, Byrd SK, Campbell KB. Functional coupling between sarcoplasmic reticulum-bound creatine kinase and Ca(2+)-ATPase. Eur J Biochem. 1993;3:973-980.
-
(1993)
Eur J Biochem
, vol.3
, pp. 973-980
-
-
Korge, P.1
Byrd, S.K.2
Campbell, K.B.3
-
71
-
-
1842471937
-
Neuroprotective mechanisms of creatine occur in the absence of mitochondrial creatine kinase
-
Klivenyi P, Calingasan NY, Starkov A, et al. Neuroprotective mechanisms of creatine occur in the absence of mitochondrial creatine kinase. Neurobiol Dis. 2004;15:610-617.
-
(2004)
Neurobiol Dis
, vol.15
, pp. 610-617
-
-
Klivenyi, P.1
Calingasan, N.Y.2
Starkov, A.3
-
72
-
-
33645894705
-
A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease
-
NINDS NET-PD Investigators
-
NINDS NET-PD Investigators. A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease. Neurology. 2006;66:664-671.
-
(2006)
Neurology
, vol.66
, pp. 664-671
-
-
-
73
-
-
0027530638
-
Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease
-
The Parkinson Study Group
-
The Parkinson Study Group. Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med. 1993;28:176-183.
-
(1993)
N Engl J Med
, vol.28
, pp. 176-183
-
-
-
75
-
-
34147177574
-
Clinical research
-
Testing a novel strategy against Parkinson's disease
-
Couzin J. Clinical research. Testing a novel strategy against Parkinson's disease. Science. 2007;315:1778.
-
(2007)
Science
, vol.315
, pp. 1778
-
-
Couzin, J.1
-
76
-
-
33846948238
-
Resistance training with creatine monohydrate improve upper-body strength in patients with Parkinson disease: A randomized trial
-
Hass CJ, Collins MA, Juncos JL. Resistance training with creatine monohydrate improve upper-body strength in patients with Parkinson disease: A randomized trial. Neurorehabil Neural Repair. 2007; 21: 107-115.
-
(2007)
Neurorehabil Neural Repair
, vol.21
, pp. 107-115
-
-
Hass, C.J.1
Collins, M.A.2
Juncos, J.L.3
-
77
-
-
0031690802
-
Biochemical and clinical consequences of inhibiting coenzyme Q 10 biosynthesis by lipid-lowering HMG- CoA reductase inhibitors (statins): A critical overview
-
Bliznakov EG, Wilkins DJ. Biochemical and clinical consequences of inhibiting coenzyme Q 10 biosynthesis by lipid-lowering HMG- CoA reductase inhibitors (statins): A critical overview. Adv Therap. 1998; 15:213-228.
-
(1998)
Adv Therap
, vol.15
, pp. 213-228
-
-
Bliznakov, E.G.1
Wilkins, D.J.2
-
78
-
-
78650728257
-
Ubiquinone - pathophysiology and present role in heart disease
-
American Dietetic Association Medical Nutrition Practice Group
-
Kones R. Ubiquinone - pathophysiology and present role in heart disease. Medical Nutrition Matters. (American Dietetic Association Medical Nutrition Practice Group). 2009;29:5-18.
-
(2009)
Medical Nutrition Matters
, vol.29
, pp. 5-18
-
-
Kones, R.1
-
79
-
-
3042706246
-
Regulation of ceramide signaling by plasma membrane coenzyme Q reductases
-
Navas P, Villalba JM. Regulation of ceramide signaling by plasma membrane coenzyme Q reductases. Methods Enzymol. 2004;378: 200-206.
-
(2004)
Methods Enzymol
, vol.378
, pp. 200-206
-
-
Navas, P.1
Villalba, J.M.2
-
80
-
-
0025979077
-
Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol
-
Stocker R, Bowry VW, Frei B. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol. Proc Natl Acad Sci U S A. 1991;88: 1646-1650.
-
(1991)
Proc Natl Acad Sci U S A
, vol.88
, pp. 1646-1650
-
-
Stocker, R.1
Bowry, V.W.2
Frei, B.3
-
81
-
-
33745410626
-
Mitochondrial disease
-
Schapira AH. Mitochondrial disease. Lancet. 2006;368:70-82.
-
(2006)
Lancet
, vol.368
, pp. 70-82
-
-
Schapira, A.H.1
-
82
-
-
0031895005
-
Mechanisms of MPTP toxicity
-
Prezedborski S, Jackson-Lewis V. Mechanisms of MPTP toxicity. Mov Disord. 1998;13 Suppl 1:35-38.
-
(1998)
Mov Disord
, vol.13
, Issue.SUPPL. 1
, pp. 35-38
-
-
Prezedborski, S.1
Jackson-Lewis, V.2
-
83
-
-
0035341492
-
Parkinson's disease, pesticides and mitochondrial dysfunction
-
Jenner P. Parkinson's disease, pesticides and mitochondrial dysfunction. Trends Neurosci. 2001;24:245-247.
-
(2001)
Trends Neurosci
, vol.24
, pp. 245-247
-
-
Jenner, P.1
-
84
-
-
0036470165
-
Distinct role of microglia in rotenone-induced degeneration of dopaminergic neurons
-
Gao HM, Hong JS, Zhang W, Liu B. Distinct role of microglia in rotenone-induced degeneration of dopaminergic neurons. J Neurosci. 2002;22:782-790.
-
(2002)
J Neurosci
, vol.22
, pp. 782-790
-
-
Gao, H.M.1
Hong, J.S.2
Zhang, W.3
Liu, B.4
-
85
-
-
0036100742
-
Environment, mitochondria, and Parkinson's disease
-
Sherer TB, Betarbet R, Greenamyre JT. Environment, mitochondria, and Parkinson's disease. Neuroscientist. 2002;8:192-197.
-
(2002)
Neuroscientist
, vol.8
, pp. 192-197
-
-
Sherer, T.B.1
Betarbet, R.2
Greenamyre, J.T.3
-
86
-
-
0029050583
-
Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease
-
Haas RH, Nasirian F, Nakano K, et al. Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease. Ann Neurol. 1995;37:714-722.
-
(1995)
Ann Neurol
, vol.37
, pp. 714-722
-
-
Haas, R.H.1
Nasirian, F.2
Nakano, K.3
-
87
-
-
0025640845
-
Anatomic disease specificity of NADH CoQ1 reductase complex I deficiency in Parkinson's disease
-
Schapira AH, Mann VM, Cooper JM, et al. Anatomic disease specificity of NADH CoQ1 reductase complex I deficiency in Parkinson's disease. J Neurochem. 1990;5:2142-2145.
-
(1990)
J Neurochem
, vol.5
, pp. 2142-2145
-
-
Schapira, A.H.1
Mann, V.M.2
Cooper, J.M.3
-
88
-
-
33646369394
-
mtDNA clock runs out for dopaminergic neurons
-
Manfredi G. mtDNA clock runs out for dopaminergic neurons. Nat Genet. 2006;38:507-508.
-
(2006)
Nat Genet
, vol.38
, pp. 507-508
-
-
Manfredi, G.1
-
89
-
-
0030612117
-
Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects
-
Shults CW, Haas RH, Passov D, Beal MF. Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects. Ann Neurol. 1997; 42:261-264.
-
(1997)
Ann Neurol
, vol.42
, pp. 261-264
-
-
Shults, C.W.1
Haas, R.H.2
Passov, D.3
Beal, M.F.4
-
90
-
-
0031594295
-
Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice
-
Beal MF, Matthews RT, Tieleman A, Shults CW. Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice. Brain Res. 1998;783:109-114.
-
(1998)
Brain Res
, vol.783
, pp. 109-114
-
-
Beal, M.F.1
Matthews, R.T.2
Tieleman, A.3
Shults, C.W.4
-
91
-
-
0026764766
-
Ubiquinone protects cultured neurons against spontaneous and excitotoxin-induced degeneration
-
Favit A, Nicoletti F, Scapagnini U, Canonico PL. Ubiquinone protects cultured neurons against spontaneous and excitotoxin-induced degeneration. J Cereb Blood Flow Metab. 1992;12:638-645.
-
(1992)
J Cereb Blood Flow Metab
, vol.12
, pp. 638-645
-
-
Favit, A.1
Nicoletti, F.2
Scapagnini, U.3
Canonico, P.L.4
-
92
-
-
0028173480
-
Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate
-
Beal MF, Henshaw DR, Jenkins BG, Rosen BR, Schulz JB. Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate. Ann Neurol. 1994;36:882-888.
-
(1994)
Ann Neurol
, vol.36
, pp. 882-888
-
-
Beal, M.F.1
Henshaw, D.R.2
Jenkins, B.G.3
Rosen, B.R.4
Schulz, J.B.5
-
93
-
-
20144369335
-
Mitochondrial mem- brane depolarization and the selective death of dopaminergic neurons by rotenone: Protective effect of coenzyme Q10
-
Moon Y, Lee KH, Park J-H, Geum D, Kim K. Mitochondrial mem- brane depolarization and the selective death of dopaminergic neurons by rotenone: Protective effect of coenzyme Q10. J Neurochem. 2005; 93:1199-1208.
-
(2005)
J Neurochem
, vol.93
, pp. 1199-1208
-
-
Moon, Y.1
Lee, K.H.2
Park, J.-H.3
Geum, D.4
Kim, K.5
-
94
-
-
0346158468
-
Coenzyme Q10 reduces the toxicity of rotenone in neuronal cultures by preserving the mitochondrial membrane potential
-
Menke T, Gille G, Reber F, et al. Coenzyme Q10 reduces the toxicity of rotenone in neuronal cultures by preserving the mitochondrial membrane potential. Biofactors. 2003;18:65-72.
-
(2003)
Biofactors
, vol.18
, pp. 65-72
-
-
Menke, T.1
Gille, G.2
Reber, F.3
-
95
-
-
0038336912
-
Coenzyme Q induces nigral mitochondrial uncoupling and prevents dopamine cell loss in a primate model of Parkinson's disease
-
Horvath TL, Diano S, Leranth C, et al. Coenzyme Q induces nigral mitochondrial uncoupling and prevents dopamine cell loss in a primate model of Parkinson's disease. Endocrinology. 2003;44: 2757-2760.
-
(2003)
Endocrinology
, vol.44
, pp. 2757-2760
-
-
Horvath, T.L.1
Diano, S.2
Leranth, C.3
-
96
-
-
31444433505
-
Parkinson's disease and brain mitochondrial dysfunction: A functional phosphorus magnetic resonance spectroscopy study
-
Rango M, Bonifati C, Bresolin N. Parkinson's disease and brain mitochondrial dysfunction: A functional phosphorus magnetic resonance spectroscopy study. J Cereb Blood Flow Metab. 2006;26: 283-290.
-
(2006)
J Cereb Blood Flow Metab
, vol.26
, pp. 283-290
-
-
Rango, M.1
Bonifati, C.2
Bresolin, N.3
-
97
-
-
72649106290
-
Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease
-
Hattingen E, Magerkurth J, Pilatus U, et al. Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease. Brain. 2009; 132:3285-297.
-
(2009)
Brain
, vol.132
, pp. 3285-3297
-
-
Hattingen, E.1
Magerkurth, J.2
Pilatus, U.3
-
98
-
-
0345451597
-
Absorption, tolerability, and effects on mitochondrial activity of oral coenzyme Q10 in Parkinsonian patients
-
Shults CW, Beal MF, Fontaine D, Nakano K, Haas RH. Absorption, tolerability, and effects on mitochondrial activity of oral coenzyme Q10 in Parkinsonian patients. Neurology. 1998;50:793-795.
-
(1998)
Neurology
, vol.50
, pp. 793-795
-
-
Shults, C.W.1
Beal, M.F.2
Fontaine, D.3
Nakano, K.4
Haas, R.H.5
-
99
-
-
0036771852
-
Parkinson Study Group. Effects of coenzyme Q10 in early Parkinson disease: Evidence for slowing of the functional decline, Phase II
-
Shults CW, Oakes D, Kieburtz K, et al; Parkinson Study Group. Effects of coenzyme Q10 in early Parkinson disease: Evidence for slowing of the functional decline, Phase II. Arch Neurol. 2002;59: 1541-1550.
-
(2002)
Arch Neurol
, vol.59
, pp. 1541-1550
-
-
Shults, C.W.1
Oakes, D.2
Kieburtz, K.3
-
100
-
-
33846115045
-
A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease
-
NINDS NET-PD Investigators
-
NINDS NET-PD Investigators. A randomized clinical trial of coen- zyme Q10 and GPI-1485 in early Parkinson disease. Neurology. 2007; 68:20-28.
-
(2007)
Neurology
, vol.68
, pp. 20-28
-
-
-
101
-
-
84872329168
-
-
Available from:, Accessed May 14, 2010
-
Effects of Coenzyme Q10 (CoQ) in Parkinson Disease (QE3). Available from: http://clinicaltrials.gov/ct2/show/NCT00740714?term=QE3+Parkinson's&rank=1. Accessed May 14, 2010.
-
Effects of Coenzyme Q10 (CoQ) In Parkinson Disease (QE3)
-
-
-
102
-
-
0032489542
-
Ascorbic acid stimulates DOPA synthesis and tyrosine hydroxylase gene expression in the human neuroblastoma cell line SK-N-SH
-
Seitz G, Gebhardt S, Beck JF, et al. Ascorbic acid stimulates DOPA synthesis and tyrosine hydroxylase gene expression in the human neuroblastoma cell line SK-N-SH. Neurosci Lett. 1998;1: 33-36.
-
(1998)
Neurosci Lett
, vol.1
, pp. 33-36
-
-
Seitz, G.1
Gebhardt, S.2
Beck, J.F.3
-
103
-
-
34248182115
-
POLANUT Study Group. Nutrient intake in an elderly population in southern France (POLANUT): Deficiency in some vitamins, minerals and omega-3 PUFA
-
Carrière I, Delcourt C, Lacroux A, Gerber M; POLANUT Study Group. Nutrient intake in an elderly population in southern France (POLANUT): Deficiency in some vitamins, minerals and omega-3 PUFA. Int J Vitam Nutr Res. 2007;77:57-65.
-
(2007)
Int J Vitam Nutr Res
, vol.77
, pp. 57-65
-
-
Carrière, I.1
Delcourt, C.2
Lacroux, A.3
Gerber, M.4
-
104
-
-
36248932727
-
Cognitive performance among the elderly and dietary fish intake: The Hordaland Health Study
-
Nurk E, Drevon CA, Refsum H, et al. Cognitive performance among the elderly and dietary fish intake: The Hordaland Health Study. Am J Clin Nutr. 2007;86:1470-1478.
-
(2007)
Am J Clin Nutr
, vol.86
, pp. 1470-1478
-
-
Nurk, E.1
Drevon, C.A.2
Refsum, H.3
-
105
-
-
36249022138
-
n-3 Fatty acid proportions in plasma and cognitive performance in older adults
-
Dullemeijer C, Durga J, Brouwer IA, et al. n-3 Fatty acid proportions in plasma and cognitive performance in older adults. Am J Clin Nutr. 2007;86:1479-1485.
-
(2007)
Am J Clin Nutr
, vol.86
, pp. 1479-1485
-
-
Dullemeijer, C.1
Durga, J.2
Brouwer, I.A.3
-
106
-
-
36249017462
-
Rethinking brain food
-
Rosenberg IH. Rethinking brain food. Am J Clin Nutr. 2007;86: 1259-1260.
-
(2007)
Am J Clin Nutr
, vol.86
, pp. 1259-1260
-
-
Rosenberg, I.H.1
-
108
-
-
21144438922
-
Dietary fatty acids and the risk of Parkinson disease: The Rotterdam study
-
de Lau LM, Bornebroek M, Witteman JC, Hofman A, Koudstaal PJ, Breteler MM. Dietary fatty acids and the risk of Parkinson disease: The Rotterdam study. Neurology. 2005;12:2040-2045.
-
(2005)
Neurology
, vol.12
, pp. 2040-2045
-
-
de Lau, L.M.1
Bornebroek, M.2
Witteman, J.C.3
Hofman, A.4
Koudstaal, P.J.5
Breteler, M.M.6
-
109
-
-
0037675047
-
Dietary intakes of fat and risk of Parkinson's disease
-
Chen H, Zhang SM, Hernan MA, Willett WC, Ascherio A. Dietary intakes of fat and risk of Parkinson's disease. Am J Epidemiol. 2003;11:1007-1014.
-
(2003)
Am J Epidemiol
, vol.11
, pp. 1007-1014
-
-
Chen, H.1
Zhang, S.M.2
Hernan, M.A.3
Willett, W.C.4
Ascherio, A.5
-
110
-
-
36249019041
-
Prospective study of dietary pattern and risk of Parkinson disease
-
Gao X, Chen H, Fung TT, et al. Prospective study of dietary pattern and risk of Parkinson disease. Am J Clin Nutr. 2007;6: 1486-1494.
-
(2007)
Am J Clin Nutr
, vol.6
, pp. 1486-1494
-
-
Gao, X.1
Chen, H.2
Fung, T.T.3
-
111
-
-
32044453838
-
Docosahexaenoic acid reduces levodopa-induced dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys
-
Samadi P, Grégoire L, Rouillard C, Bédard PJ, Di Paolo T, Lévesque D. Docosahexaenoic acid reduces levodopa-induced dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys. Ann Neurol. 2006;59:282-288.
-
(2006)
Ann Neurol
, vol.59
, pp. 282-288
-
-
Samadi, P.1
Grégoire, L.2
Rouillard, C.3
Bédard, P.J.4
Di Paolo, T.5
Lévesque, D.6
-
112
-
-
42049096538
-
Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease
-
Bousquet M, Saint-Pierre M, Julien C, Salem NJ, Cicchetti F, Calon F. Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease. FASEB J. 2008;22:1213-1225.
-
(2008)
FASEB J
, vol.22
, pp. 1213-1225
-
-
Bousquet, M.1
Saint-Pierre, M.2
Julien, C.3
Salem, N.J.4
Cicchetti, F.5
Calon, F.6
-
113
-
-
47249137372
-
Can we prevent Parkinson's disease with n-3 polyunsaturated fatty acids?
-
Calon F, Cicchetti F. Can we prevent Parkinson's disease with n-3 polyunsaturated fatty acids? Future Lipidol. 2008;2:133-137.
-
(2008)
Future Lipidol
, vol.2
, pp. 133-137
-
-
Calon, F.1
Cicchetti, F.2
-
114
-
-
0030769660
-
Rapid incorporation of docosahexaenoic acid from dietary sources into brain microsomal, synaptosomal and mitochondrial membranes in adult mice
-
Suzuki H, Manabe S, Wada O, Crawford MA. Rapid incorporation of docosahexaenoic acid from dietary sources into brain microsomal, synaptosomal and mitochondrial membranes in adult mice. Int J Vitam Nutr Res. 1997;67:272-278.
-
(1997)
Int J Vitam Nutr Res
, vol.67
, pp. 272-278
-
-
Suzuki, H.1
Manabe, S.2
Wada, O.3
Crawford, M.A.4
-
115
-
-
0034571235
-
DNA damage in brain mitochondria caused by aging and MPTP treatment
-
Mandavilli BS, Ali SF, Van Houten B. DNA damage in brain mito- chondria caused by aging and MPTP treatment. Brain Res. 2000; 885:45-52.
-
(2000)
Brain Res
, vol.885
, pp. 45-52
-
-
Mandavilli, B.S.1
Ali, S.F.2
Van Houten, B.3
-
116
-
-
0026748832
-
Effect of docosahexaenoic acid on membrane fluidity and function in intact cultured Y-79 retinoblastoma cells
-
Treen M, Uauy RD, Jameson DM, Thomas VL, Hoffman DR. Effect of docosahexaenoic acid on membrane fluidity and function in intact cultured Y-79 retinoblastoma cells. Arch Biochem Biophys. 1992;294:564-570.
-
(1992)
Arch Biochem Biophys
, vol.294
, pp. 564-570
-
-
Treen, M.1
Uauy, R.D.2
Jameson, D.M.3
Thomas, V.L.4
Hoffman, D.R.5
-
117
-
-
33748983343
-
Modulation of phosphoinositide-protein kinase C signal transduction by omega-3 fatty acids: Implications for the pathophysiology and treatment of recurrent neuropsychiatric illness
-
McNamara RK, Ostrander M, Abplanalp W, Richtand NM, Benoit SC, Clegg DJ. Modulation of phosphoinositide-protein kinase C signal transduction by omega-3 fatty acids: Implications for the pathophysiology and treatment of recurrent neuropsychiatric illness. Prostaglandins Leukot Essent Fatty Acids. 2006;75:237-257.
-
(2006)
Prostaglandins Leukot Essent Fatty Acids
, vol.75
, pp. 237-257
-
-
McNamara, R.K.1
Ostrander, M.2
Abplanalp, W.3
Richtand, N.M.4
Benoit, S.C.5
Clegg, D.J.6
-
118
-
-
34347359673
-
Rejuvenation protects neurons in mouse models of Parkinson's disease
-
Chan CS, Guzman JN, Ilijic E, et al. Rejuvenation protects neurons in mouse models of Parkinson's disease. Nature. 2007;447: 1081-1086.
-
(2007)
Nature
, vol.447
, pp. 1081-1086
-
-
Chan, C.S.1
Guzman, J.N.2
Ilijic, E.3
-
119
-
-
34547131318
-
Novel metabolism of docosahexaenoic acid in neural cells
-
Kim HY. Novel metabolism of docosahexaenoic acid in neural cells. J Biol Chem. 2007;282:18661-18665.
-
(2007)
J Biol Chem
, vol.282
, pp. 18661-18665
-
-
Kim, H.Y.1
-
122
-
-
78650750137
-
Fish oil protects against diseases like Parkinson's
-
Mar 20, Available at:, Accessed May 14, 2010
-
Bazan N. Fish oil protects against diseases like Parkinson's. Science Daily. Mar 20, 2009. Available at: http://www.sciencedaily.com/releases/2009/04/090419133844.htm. Accessed May 14, 2010.
-
(2009)
Science Daily
-
-
Bazan, N.1
-
123
-
-
61849141189
-
for the International Society for the Study of Fatty Acids and Lipids, ISSFAL. α-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans
-
Brenna JT, Salem N, Sinclair AJ, Cunnane SC; for the International Society for the Study of Fatty Acids and Lipids, ISSFAL. α-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot Essent Fatty Acids. 2009;80:85-91.
-
(2009)
Prostaglandins Leukot Essent Fatty Acids
, vol.80
, pp. 85-91
-
-
Brenna, J.T.1
Salem, N.2
Sinclair, A.J.3
Cunnane, S.C.4
-
124
-
-
69549103671
-
Workshop on DHA as a Required Nutrient: Can the rat liver maintain normal brain DHA metabolism in the absence of dietary DHA?
-
Rapoport SI, Miki Igarashi M. Workshop on DHA as a Required Nutrient: Can the rat liver maintain normal brain DHA metabolism in the absence of dietary DHA? Prostaglandins Leukot Essent Fatty Acids. 2009;81:119-123.
-
(2009)
Prostaglandins Leukot Essent Fatty Acids
, vol.81
, pp. 119-123
-
-
Rapoport, S.I.1
Miki, I.M.2
-
125
-
-
0036550614
-
New clues about vitamin D functions in the nervous system
-
Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab. 2002;13:100-105.
-
(2002)
Trends Endocrinol Metab
, vol.13
, pp. 100-105
-
-
Garcion, E.1
Wion-Barbot, N.2
Montero-Menei, C.N.3
Berger, F.4
Wion, D.5
-
126
-
-
0030661630
-
High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease
-
Sato Y, Kikuyama M, Oizumi K. High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease. Neurology. 1997;49:1273-1278.
-
(1997)
Neurology
, vol.49
, pp. 1273-1278
-
-
Sato, Y.1
Kikuyama, M.2
Oizumi, K.3
-
127
-
-
54049152001
-
Prevalence of vitamin D insufficiency in patients with Parkinson disease and Alzheimer disease
-
Evatt ML, Delong MR, Khazai N, Rosen A, Triche S, Tangpricha V. Prevalence of vitamin D insufficiency in patients with Parkinson disease and Alzheimer disease. Arch Neurol. 2008;65:1348-1352.
-
(2008)
Arch Neurol
, vol.65
, pp. 1348-1352
-
-
Evatt, M.L.1
Delong, M.R.2
Khazai, N.3
Rosen, A.4
Triche, S.5
Tangpricha, V.6
-
128
-
-
67650483354
-
Association between 25- hydroxyvitamin D levels and cognitive performance in middle-aged and old European men
-
Lee DM, Tajar A, Ulubaev A, et al. Association between 25- hydroxyvitamin D levels and cognitive performance in middle-aged and old European men. J Neurol Neurosurg Psychiatry. 2009;80: 722-729.
-
(2009)
J Neurol Neurosurg Psychiatry
, vol.80
, pp. 722-729
-
-
Lee, D.M.1
Tajar, A.2
Ulubaev, A.3
-
129
-
-
74049162336
-
25-hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services
-
Buell JS, Dawson-Hughes B, Scott TM, et al. 25-hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology. 2010;74:18-26.
-
(2010)
Neurology
, vol.74
, pp. 18-26
-
-
Buell, J.S.1
Dawson-Hughes, B.2
Scott, T.M.3
-
130
-
-
3843080805
-
Mortality in Parkinson's disease and its association with dementia and depression
-
Hughes TA, Ross HF, Mindham RHS, Spokes EGS. Mortality in Parkinson's disease and its association with dementia and depression. Acta Neurol Scand. 2004;110:118-123.
-
(2004)
Acta Neurol Scand
, vol.110
, pp. 118-123
-
-
Hughes, T.A.1
Ross, H.F.2
Mindham, R.H.S.3
Spokes, E.G.S.4
-
131
-
-
10744227022
-
Body composition in advanced-stage Parkinson's disease
-
Petroni ML, Albani G, Bicchiega V, et al. Body composition in advanced-stage Parkinson's disease. Acta Diabetol. 2003; 40 Suppl 1: 187-190.
-
(2003)
Acta Diabetol
, vol.40
, Issue.SUPPL. 1
, pp. 187-190
-
-
Petroni, M.L.1
Albani, G.2
Bicchiega, V.3
-
132
-
-
14844286839
-
Recent developments in vitamin D deficiency and muscle weakness among elderly people
-
Venning G. Recent developments in vitamin D deficiency and muscle weakness among elderly people. BMJ. 2005;330:524-526.
-
(2005)
BMJ
, vol.330
, pp. 524-526
-
-
Venning, G.1
-
133
-
-
33745603708
-
Calcium and vitamin D in the prevention of osteoporotic fractures
-
Francis RM, Anderson FH, Patel S, Sahota O, van Staa TP. Calcium and vitamin D in the prevention of osteoporotic fractures. QJM. 2006; 99:355-363.
-
(2006)
QJM
, vol.99
, pp. 355-363
-
-
Francis, R.M.1
Anderson, F.H.2
Patel, S.3
Sahota, O.4
van Staa, T.P.5
-
134
-
-
63849282684
-
Prevention of nonvertebral fractures with oral vitamin D and dose dependency: A meta-analysis of randomized controlled trials
-
Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: A meta-analysis of randomized controlled trials. Arch Intern Med. 2009; 169:551-561.
-
(2009)
Arch Intern Med
, vol.169
, pp. 551-561
-
-
Bischoff-Ferrari, H.A.1
Willett, W.C.2
Wong, J.B.3
-
135
-
-
0346732368
-
Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): The Longitudinal Aging Study Amsterdam
-
Visser M, Deeg JH Dorly, Lips P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): The Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab. 2003;88:5766-5772.
-
(2003)
J Clin Endocrinol Metab
, vol.88
, pp. 5766-5772
-
-
Visser, M.1
Dorly, D.J.H.2
Lips, P.3
-
136
-
-
34347243589
-
Vitamin D status predicts physical performance and its decline in older persons
-
Wicherts IS, van Schoor NM, Boeke AJP, et al. Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab. 2007;92:2058-2065
-
(2007)
J Clin Endocrinol Metab
, vol.92
, pp. 2058-2065
-
-
Wicherts, I.S.1
van Schoor, N.M.2
Boeke, A.J.P.3
-
137
-
-
34347209984
-
Vitamin D and rehabilitation: Improving functional outcomes
-
Shinchuk L, Holick MF. Vitamin D and rehabilitation: Improving functional outcomes. Nutr Clin Pract. 2007;22:297-304.
-
(2007)
Nutr Clin Pract
, vol.22
, pp. 297-304
-
-
Shinchuk, L.1
Holick, M.F.2
-
138
-
-
0034044413
-
Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement
-
Glerup H, Mikkelsen K, Poulsen L, et al. Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement. Calcif Tissue Int. 2000;6:419-424.
-
(2000)
Calcif Tissue Int
, vol.6
, pp. 419-424
-
-
Glerup, H.1
Mikkelsen, K.2
Poulsen, L.3
-
139
-
-
33846569956
-
A higher dose of vitamin D reduces the risk of falls in nursing home residents: A randomized, multiple-dose study
-
Broe KE, Chen TC, Weinberg J, Bischoff-Ferrari HA, Holick MF, Kiel DP. A higher dose of vitamin D reduces the risk of falls in nursing home residents: A randomized, multiple-dose study. J Am Geriatr Soc. 2007;55:234-239.
-
(2007)
J Am Geriatr Soc
, vol.55
, pp. 234-239
-
-
Broe, K.E.1
Chen, T.C.2
Weinberg, J.3
Bischoff-Ferrari, H.A.4
Holick, M.F.5
Kiel, D.P.6
-
140
-
-
38349019697
-
Effects of ergocalciferol added to calcium on the risk of falls in elderly high-risk women
-
Prince RL, Austin N, Devine A, Dick IM, Bruce D, Zhu K. Effects of ergocalciferol added to calcium on the risk of falls in elderly high-risk women. Arch Intern Med. 2008;168:103-108.
-
(2008)
Arch Intern Med
, vol.168
, pp. 103-108
-
-
Prince, R.L.1
Austin, N.2
Devine, A.3
Dick, I.M.4
Bruce, D.5
Zhu, K.6
-
141
-
-
63649139745
-
Long-term effects of giving nursing home residents bread fortified with 125 micrograms (5000 IU) vitamin D3 per daily serving
-
Mocanu V, Stitt PA, Costan AR, et al. Long-term effects of giving nursing home residents bread fortified with 125 micrograms (5000 IU) vitamin D3 per daily serving. Am J Clin Nutr. 2009;89:1132-1137.
-
(2009)
Am J Clin Nutr
, vol.89
, pp. 1132-1137
-
-
Mocanu, V.1
Stitt, P.A.2
Costan, A.R.3
-
142
-
-
34247187985
-
Vitamin D and Parkinson's disease: A hypothesis
-
Newmark HL, Newmark J. Vitamin D and Parkinson's disease: a hypothesis. Mov Disord. 2007;22(4):461-468.
-
(2007)
Mov Disord
, vol.22
, Issue.4
, pp. 461-468
-
-
Newmark, H.L.1
Newmark, J.2
-
143
-
-
77955029222
-
Serum vitamin D and the risk of Parkinson disease
-
Knekt P, Kilkkinen A, Rissanen H, Marniemi J, Sääsksjärvi K, Heliövaara M. Serum vitamin D and the risk of Parkinson disease. Arch Neurol. 2010;67(7):808-811.
-
(2010)
Arch Neurol
, vol.67
, Issue.7
, pp. 808-811
-
-
Knekt, P.1
Kilkkinen, A.2
Rissanen, H.3
Marniemi, J.4
Sääsksjärvi, K.5
Heliövaara, M.6
-
144
-
-
77955047827
-
Beyond Vitamin Status Is There a Role for Vitamin D in Parkinson Disease?
-
Evatt ML. Beyond Vitamin Status Is There a Role for Vitamin D in Parkinson Disease? Arch Neurol. 2010;67(7):795-797.
-
(2010)
Arch Neurol
, vol.67
, Issue.7
, pp. 795-797
-
-
Evatt, M.L.1
-
145
-
-
52649121742
-
Vitamin D receptor: Molecular signaling and actions of nutritional ligands in disease prevention
-
Haussler MR, Haussler CA, Bartik L, et al. Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention. Nutr Rev. 2008;66(Suppl2):S98-S112.
-
(2008)
Nutr Rev
, vol.66
, Issue.SUPPL. 2
-
-
Haussler, M.R.1
Haussler, C.A.2
Bartik, L.3
-
146
-
-
10044272155
-
Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain
-
Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat. 2005;29(1):21-30.
-
(2005)
J Chem Neuroanat
, vol.29
, Issue.1
, pp. 21-30
-
-
Eyles, D.W.1
Smith, S.2
Kinobe, R.3
Hewison, M.4
McGrath, J.J.5
-
147
-
-
77954600272
-
Vitamin D and risk of cognitive decline in elderly persons
-
Llewellyn DJ, Lang IA, Langa KM, et al. Vitamin D and risk of cognitive decline in elderly persons. Arch Int Med. 2010;170(13); 1135-1141.
-
(2010)
Arch Int Med
, vol.170
, Issue.13
, pp. 1135-1141
-
-
Llewellyn, D.J.1
Lang, I.A.2
Langa, K.M.3
-
148
-
-
56049118465
-
Vitamin D and neurocognitive dysfunction: Preventing Decline?
-
Buell JS, Dawson-Hughes B. Vitamin D and neurocognitive dys- function: preventing Decline? Mol Aspects Med. 2008;29(6): 415-422.
-
(2008)
Mol Aspects Med
, vol.29
, Issue.6
, pp. 415-422
-
-
Buell, J.S.1
Dawson-Hughes, B.2
|